Regulus Therapeutics Inc (RGLS)
2.20
-0.02
(-0.90%)
USD |
NASDAQ |
Apr 25, 10:42
Regulus Therapeutics Price to Book Value: 6.799 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 6.861 |
| April 23, 2024 | 6.985 |
| April 22, 2024 | 6.799 |
| April 19, 2024 | 6.583 |
| April 18, 2024 | 6.861 |
| April 17, 2024 | 7.232 |
| April 16, 2024 | 7.912 |
| April 15, 2024 | 8.592 |
| April 12, 2024 | 8.654 |
| April 11, 2024 | 8.592 |
| April 10, 2024 | 8.097 |
| April 09, 2024 | 8.345 |
| April 08, 2024 | 8.252 |
| April 05, 2024 | 7.850 |
| April 04, 2024 | 7.788 |
| April 03, 2024 | 8.066 |
| April 02, 2024 | 8.406 |
| April 01, 2024 | 8.654 |
| March 28, 2024 | 8.901 |
| March 27, 2024 | 8.901 |
| March 26, 2024 | 8.793 |
| March 25, 2024 | 8.716 |
| March 22, 2024 | 8.298 |
| March 21, 2024 | 8.592 |
| March 20, 2024 | 7.726 |
| Date | Value |
|---|---|
| March 19, 2024 | 7.371 |
| March 18, 2024 | 7.294 |
| March 15, 2024 | 6.521 |
| March 14, 2024 | 7.556 |
| March 13, 2024 | 2.335 |
| March 12, 2024 | 2.268 |
| March 11, 2024 | 1.326 |
| March 08, 2024 | 1.327 |
| March 07, 2024 | 1.356 |
| March 06, 2024 | 1.432 |
| March 05, 2024 | 1.413 |
| March 04, 2024 | 1.422 |
| March 01, 2024 | 1.422 |
| February 29, 2024 | 1.403 |
| February 28, 2024 | 1.422 |
| February 27, 2024 | 1.437 |
| February 26, 2024 | 1.356 |
| February 23, 2024 | 1.394 |
| February 22, 2024 | 1.461 |
| February 21, 2024 | 1.442 |
| February 20, 2024 | 1.475 |
| February 16, 2024 | 1.461 |
| February 15, 2024 | 1.413 |
| February 14, 2024 | 1.413 |
| February 13, 2024 | 1.489 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4012
Minimum
Mar 27 2023
12.17
Maximum
Dec 22 2020
1.895
Average
1.135
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals Inc | 6.259 |
| ADMA Biologics Inc | 10.72 |
| FibroGen Inc | -- |
| Protara Therapeutics Inc | 0.4886 |
| Amylyx Pharmaceuticals Inc | 0.2862 |
Price to Book Value Related Metrics
| Price | 2.20 |
| Earnings Yield | -71.82% |
| Market Cap | 144.02M |